Robin Edwards is a seasoned leader in translational medicine, specializing in translational pathology and biomarker assay development. With extensive experience in building and leading translational teams, Robin has contributed to clinical drug development at major companies, including Bristol-Myers Squibb, Pfizer, and Daiichi Sankyo. Currently serving as Vice President of Translational Medicine at MacroGenics, Robin consults on precision medicine and biomarker strategies through Robin H. Edwards Consulting, LLC. Robin holds an M.D. from Case Western Reserve University School of Medicine and furthered their education in pathology and hematopathology at the University of Pennsylvania School of Medicine.
This person is not in any teams
This person is not in any offices